How CathWorks Drew from Many Voices to Improve Cardiac Care, Build a Quick Path to Acquisition

In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.Founded in 2013, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:38) - State of Minnesota / Newmarker’s Newsmakers(00:08:00) - Medtronic Structural Heart President Nina Goodheart to retire(00:09:11) - Siemens Healthineers unveils $12M R&D facility in Ireland(00:12:10) - Stryker officials have high hopes for 2026 with Mako RPS(00:13:54) - Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short(00:16:19) - Medtronic reportedly must pay Applied Medical $382M over antitrust suit(00:21:52) - FOMO Interview – Girish Naganathan, EVP, Chief Technology Officer, Dexcom(00:32:28) - Keynote Interview – Ramin Mousavi, President, CEO, CathWorks

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead. Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com. At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies(00:06:10) - This is not your Father’s TAVR(00:08:00) - Terms of the Medtronic investment(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical(00:29:50) - How is minimally invasive technology changing?(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular(00:35:30) - What makes a good neurosurgeon?(00:39:01) - Choosing impact over intimacy(00:44:50) - What do patients fear more than death?(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next. In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit www.averna.com to learn more. We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies. To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup(00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter(00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4(00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall(00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies(00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna(00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health. In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success. Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand. MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A(00:13:08) - All the big news from Boston Scientific(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics

Innovation doesn’t happen by accident. It happens when leaders intentionally design the systems that allow curiosity, experimentation, and good ideas to survive. In this episode of the Women in MedTech podcast, host Kayleen Brown sits down with Dr. Rebecca Gottlieb, VP of Advanced Sensor Technologies at Biolinq, to explore what it really takes to build innovation engines inside regulated MedTech environments. From early clinical work with artificial heart patients, to more than two decades of sensor innovation at Medtronic, to leading advanced biosensing platforms at Biolinq, Rebecca explains why curiosity isn’t just a mindset — it’s a leadership strategy. Kayleen also welcomes Chris Dawson, Head of Biosensing at TTP PLC, to unpack what curiosity looks like in practice: how multidisciplinary teams explore what’s possible, retire risk early, and build systems that support innovation without compromising reliability or regulatory rigor. Thank you to TTP for your support, to learn more visit: https://www.ttp.com. Before you go, make sure to download your complimentary e-books from TTP today!  Rethinking Regulatory Compliance -  How to turn regulatory demands in MedTech into development strengths Optimising Bluetooth Connectivity in Implantable Medical Devices Automated Biosensor Testing for the Development of Continuous Health Monitors *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players:https://women-in-medtech.castos.com/subscribe Follow us on YouTube:https://www.youtube.com/@DeviceTalks Want access to the complete DeviceTalks Podcast Network (DTPN)?Follow us at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why innovation systems matter in MedTech(00:00:01) - Introducing in-studio guest, Chris Dawson, TTP(00:00:02) - What innovation looks like inside multidisciplinary teams(00:00:03) - Start of keynote interview with Rebecca Gottlieb, Biolinq(00:00:04) - From startup to Medtronic: scaling innovation across environments(00:00:05) - Internal venture programs: designing systems for ideas to surface(00:00:06) - Leadership as barrier removal, not control(00:00:07) - Why Rebecca chose Biolinq: platforms, microneedles, and possibility(00:00:08) - Rethinking glucose monitoring for Type 2 diabetes(00:00:09) - FDA De Novo clearance and sustaining teams through long timelines(00:00:10) - The future of biosensing: DNA-based receptors and new analytes(00:00:11) - Leadership reflections and closing: curiosity as an innovation engine

HAPPY NEW YEAR! Host Tom Salemi squeezes in that salutation one final time in our first episode of DeviceTalks Weekly. In this episode, Managing Editor Kayleen Brown shines the FOMO spotlight on a possible new approach to treating stroke victims. Liane Teplitsky, now executive chair of Executive Chair of the Board of Directors of Carvolix, explains how an early-stage robot could give more interventionalists the power to help stroke victims. Tom Salemi and MassDevice’s Chris Newmarker Vensana Capital Co-founder Justin Klein, MD, as a temporary member of the Newsmaker team where the review the highs and lows of the first full week of the year. Tom and Justin then talk about the state of MedTech venture capital starting with the HSBC annual report. Finally, Chris Newmarker hosts our keynote interview featuring Lisa Anderson, president of Paragonix Technologies, which is upending how donated organs are stored for transportation before transplantation. Newsmakers include the late Tom Fogarty, Teleflex, Staar Surgical, Alcon, W.L. Gore, Conformal, and Johnson & Johnson MedTech. You can access the HSBC report here - https://www.hsbcinnovationbanking.com/us/en/resources/2025-annual-venture-healthcare-report?cid=B:OSOC:10937621680:10893300135 Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:40) - Meet Justin Klein, MD, co-founder managing partner, Vensana Capital(00:08:42) - MedTech pioneer Dr. Tom Fogarty passes away at 91(00:14:28) - Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance(00:17:20) - Staar Surgical to terminate Alcon deal after stockholder vote W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:20:10) - W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:24:45) - Johnson & Johnson MedTech submits Ottava surgical robot to FDA(00:27:19) - Tom and Justin review HSCB report(00:46:54) - FOMO Interview with Kayleen Brown and Liane Teplitsky(00:57:38) - Keynote interview with Lisa Anderson, President, Paragonix Technologies

Happy New Year DeviceTalkers! We’re excited to start 2026, but not before give a proper goodbye to 2025 by picking our top tech, biggest newsmaker (company or person), and biggest news of the year. Listen the selection from our editorial team – Kayleen Brown, Jim Hammerand, Chris Newmarker, Tom Salemi, and Sean Whooley – and a special guest, Chris Landon, CEO of Natus Medical. Just before we share our final thought, Brown gets a glimpse of the future of Ambulatory Surgery Centers from Oliver Keown, MD, CEO and founder of Oath Surgical. They recording the FOMO interview at DeviceTalks West.  To all of our listeners, thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Thank you from Tom and Kayleen(00:05:05) - Overview of the Episode(00:07:00) - FOMO Interview – Oliver Keown, MD, CEO of Oath Surgical on ASCs(00:17:20) - 2025 Year in Review(00:19:40) - Introduction of Guest Panelist – Chris Landon, CEO, Natus Medical(00:25:20) - Our choices of medical technology of the year(00:47:50) - Newsmaker of the year – Company or Individual(01:01:40) - Biggest news story of the year

In this episode of the DeviceTalks Weekly podcast, we give the entire stage to Medtronic’s surgical robotics business in honor of the FDA’s approving the Hugo RAS system for urological procedures. This episode is sponsored by Confluent Medical Technologies. Visit http://confluentmedical.com/ for more information. First, MassDevice editor Chris Newmarker asks James Porter, MD, a practicing surgeon and CMO of Medtronic’s surgical business, why he sees as a better alternative for hospitals and surgeons. Then, Host Tom Salemi visits with Rajit Kamal, the VP of the company’s surgical robotics building to learn what’s next. How will the company take on the massive incumbent, Intuitive. We’ll also visit with Gayle Grimes, author of MassDevice’s Medtech Market Intelligence Report on surgical robotics. Go here to learn more. https://www.massdevice.com/product/robotic-surgery/ This week’s Newmarker’s Newsmakers are CMR Surgical, Johnson & Johnson MedTech, Olympus, Nephrodite, and Medline. Go here to listen to Rajit Kamal’s first appearance on the DeviceTalks Weekly podcast: https://www.devicetalks.com/velys-inhance-and-other-reasons-why-depuy-synthes-sees-ortho-opportunities-2021s-top-dtw-episodes/ *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:55) - Surgical Report Gayle Grimes(00:10:56) - CMR Surgical wins FDA clearance for next-gen Versius Plus surgical robot in cholecystectomy(00:13:22) - Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA(00:15:03) - Olympus launches second medtech investment fund with $150M(00:16:08) - Continuous dialysis implant wins FDA Breakthrough Device Designation(00:18:33) - Medline prices $7B IPO, begins trading on Nasdaq(00:23:00) - Confluent Medical, Part 1(00:26:40) - Interview with James Porter, MD, CMO, Robotic Surgical Technologies & Digital Technologies, Medtronic(00:52:43) - Confluent Medical, Part 2(00:56:22) - Interview with Rajit Kamal, VP and GM, Robotic Surgical Technologies, Medtronic

Earned trust becomes leadership capital — and in MedTech, it compounds faster than most leaders realize. In this episode of the Women in MedTech podcast, host Kayleen Brown talks with Edwards Lifesciences’ Sarah Huoh, Corporate Vice President of Public Affairs, about why trust has to be built and demonstrated long before it can be communicated — and what it takes to earn credibility across patients, policy, and teams. Kayleen also welcomes Brittany Mai, Marketing Manager at Confluent Medical Technologies, to discuss what trust looks like across the MedTech ecosystem — how strong partnerships get built, how alignment happens across organizations, and why execution depends on credibility that’s earned over time. Thank you to Confluent Medical Technologies for your support. Visit ➡ https://confluentmedical.com/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why trust matters in MedTech(00:02:13) - Introducing In-studio guest, Brittany Mai, Confluent Medical Technologies(00:17:34) - Start of Keynote Interview with Sarah Huoh, Edwards Lifesciences(00:18:31) - Leadership foundations: first job lessons that still show up in the C-suite(00:29:32) - Career moves with strategy: how Sarah chose roles that widened her impact(00:32:44) - Public affairs as a business function: reputation, policy, and patient trust(00:38:30) - “Team of teams” leadership: alignment, execution, and internal credibility(00:39:23) - Operating at global scale: keeping 16,000 employees anchored on patients(00:42:18) - Patient education as market reality: reducing fear, friction, and confusion(00:48:49) - Trust as leadership capital: demonstrated behavior, not messaging(01:06:52) - Conclusion: key takeaways on earning trust that compounds

In this episode of DeviceTalks Weekly, Host Tom Salemi gets the dos and don’t’s of entrepreneurship with serially successful MedTech leader Ray Cohen. In this keynote address from DeviceTalks West, Cohen delivers a master class on how to build a successful MedTech, using Boston Scientific’s $3.7 billion acquisition as a case study. DeviceTalks Managing Editor Kayleen Brown explores the future of connected health with Dr. Sarah Matt, author of the new book, The Borderless Healthcare Revolution. Go to DrSarahMatt.com to order the book. Thank you to Lighteum Medical for sponsoring this episode of DeviceTalks Weekly. Go to http://lighteum.com/ for more information. Want to meet with Lighteum Medical in person at MD&M West? Book time with them here: https://calendly.com/lighteum-medical/mdmwest  MassDevice’s Chris Newmarker kicks us off with his Newmarker’s Newsmakers – SS Innovations, Boston Scientific, Teleflex, Resmed, Telefex Medical. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - Newmarker's Newsmakers(00:18:51) - Part 1 of interview with Jose Maeso, CTO of Lighteum Medical(00:22:35) - FOMO Interview with Dr. Sarah Matt(00:33:28) - Insights from Ray Cohen on MedTech Success(00:44:18) - Key Elements for Starting a Company(00:48:12) - Part 2 of the interview with Lighteum Medical(00:50:50) - The Role of Clinical Support and Physician Champions(01:00:32) - Navigating the IPO Process and Market Dynamics(01:09:27) - The Acquisition by Boston Scientific and Lessons Learned(01:14:31) - Key Takeaways for Aspiring Entrepreneurs